SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-292999
Filing Date
2014-08-04
Accepted
2014-08-04 13:30:14
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d766384d10q.htm 10-Q 308304
2 EX-31.1 d766384dex311.htm EX-31.1 9220
3 EX-31.2 d766384dex312.htm EX-31.2 9572
4 EX-32.1 d766384dex321.htm EX-32.1 5362
  Complete submission text file 0001193125-14-292999.txt   2617244

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20140630.xml EX-101.INS 357455
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20140630.xsd EX-101.SCH 25382
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20140630_cal.xml EX-101.CAL 17588
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20140630_def.xml EX-101.DEF 120638
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20140630_lab.xml EX-101.LAB 210033
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20140630_pre.xml EX-101.PRE 121607
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 141012242
SIC: 2834 Pharmaceutical Preparations